Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 21, 2022 at 04:45 am EDT
Share
Chimin Health Management Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 285.49 million compared to CNY 253.77 million a year ago. Revenue was CNY 285.49 million compared to CNY 253.77 million a year ago. Net income was CNY 70.68 million compared to CNY 39.94 million a year ago. Basic earnings per share from continuing operations was CNY 0.15 compared to CNY 0.0857 a year ago. Diluted earnings per share from continuing operations was CNY 0.15 compared to CNY 0.0857 a year ago.
Chimin Health Management Co., Ltd., formerly Zhejiang Chimin Pharmaceutical CO., Ltd, is primarily engaged in the research, development, manufacture and sale of infusion and injection and puncture machinery products. The Company primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The Company distributes its products within domestic market and to overseas markets.